Page 323 - Read Online

Page 14 of 14 Gooding et al. J Cancer Metastasis Treat 2019;5:41 I http://dx.doi.org/10.20517/2394-4722.2019.11

Front Oncol 2013;3:120.
89. Montagut C, Tusquets I, Ferrer B, Corominas JM, Bellosillo B, et al. Activation of nuclear factor-kappa B is linked to resistance to
neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer 2006;13:607-16.
90. Liu H, Patel MR, Prescher JA, Patsialou A, Qian D, et al. Cancer stem cells from human breast tumors are involved in spontaneous
metastases in orthotopic mouse models. Proc Natl Acad Sci U S A 2010;107:18115-20.
91. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, et al. Biological and molecular heterogeneity of breast cancers correlates with
their cancer stem cell content. Cell 2010;140:62-73.
92. Louie E, Nik S, Chen JS, Schmidt M, Song B, et al. Identification of a stem-like cell population by exposing metastatic breast cancer cell
lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res 2010;12:R94.
93. Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev
Mol Cell Biol 2019;20:69-84.
94. Li F, Tiede B, Massague J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 2007;17:3-14.
95. Prager BC, Xie Q, Bao S, Rich JN. Cancer stem cells: the architects of the tumor ecosystem. Cell Stem Cell 2019;24:41-53.
96. Schatton T, Frank NY, Frank MH. Identification and targeting of cancer stem cells. Bioessays 2009;31:1038-49.
97. Jaksch M, Munera J, Bajpai R, Terskikh A, Oshima RG. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem
cell, colon cancer, and melanoma cell lines. Cancer Res 2008;68:7882-6.
98. Velasco-Velazquez MA, Popov VM, Lisanti MP, Pestell RG. The role of breast cancer stem cells in metastasis and therapeutic
implications. Am J Pathol 2011;179:2-11.
99. Sin WC, Lim CL. Breast cancer stem cells-from origins to targeted therapy. Stem Cell Investig 2017;4:96.
100. Zhou M, Hou Y, Yang G, Zhang H, Tu G, et al. LncRNA-Hh strengthen cancer stem cells generation in twist-positive breast cancer via
activation of hedgehog signaling pathway. Stem Cells 2016;34:55-66.
101. Padua Alves C, Fonseca AS, Muys BR, de Barros ELBR, Burger MC, et al. Brief report: The lincRNA Hotair is required for epithelial-to-
mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells 2013;31:2827-32.
102. Chen YM, Liu Y, Wei HY, Lv KZ, Fu P. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and
invasion of breast cancer cells. Tumour Biol 2016;37:10861-70.
103. Chen S, Zhu J, Wang F, Guan Z, Ge Y, et al. LncRNAs and their role in cancer stem cells. Oncotarget 2017;8:110685-92.
104. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. The epithelial-mesenchymal transition generates cells with properties of stem
cells. Cell 2008;133:704-15.
105. Valadkhan S, Valencia-Hipolito A. lncRNAs in stress response. Curr Top Microbiol Immunol 2016;394:203-36.
106. Piva R, Belardo G, Santoro MG. NF-kappaB: a stress-regulated switch for cell survival. Antioxid Redox Signal 2006;8:478-86.
107. Kroger C, Afeyan A, Mraz J, Eaton EN, Reinhardt F, et al. Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast
cancer cells. Proc Natl Acad Sci U S A 2019;116:7353-62.